Delirium
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Inpatients at Kyoto University Hospital (from January 1, 2020, to December 31, 2024). 2. Aged 65 years or older. 3. Patients who started blonanserin transdermal patches for either prevention or treatment of delirium.
Exclusion criteria
Exclusion criteria: Patients who were already receiving regular administration of antipsychotics or high-potency sedatives at the time of admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of daytime over-sedation during the first 3 days after initiation (percentage of patients with at least one record of RASS -2 or lower based on nursing records or RASS scores between 8:00 and 21:00). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Delirium cure rate at Day 2 (in the cohort with delirium). 2. Delirium incidence/recurrence rate by Day 2 (in the cohort without delirium). 3. Rate of change or discontinuation of the application strategy. 4. Rate of new addition or dose increase of other psychotropics or sedatives. | — |
Countries
Japan
Contacts
Kyoto University Hospital Department of Primary Care and Emergency Medicine